Month: September 2021

TORONTO, Sept. 22, 2021 (GLOBE NEWSWIRE) — O2Gold Inc. (“O2Gold” or the “Company”) (TSXV: OTGO) is pleased to announce that it has completed its shares for debt settlement with Geominas Serviminas JV that was previously announced on September 3, 2021 (the “Shares for Debt Settlement”). Pursuant to the Shares for Debt Settlement, the Company has issued 800,323 common shares of the Company at a deemed price of $0.22 per share in satisfaction of outstanding debt of approximately $176,000. The common shares issued pursuant to the Shares for Debt Settlement are subject to a four month and one day hold period expiring on January 22, 2022. About O2Gold O2Gold is a mineral exploration company with activities in Colombia. The Company’s contiguous 30,000 ha land package includes several brownfields and largely under-explored greenfields. For...

BOISE, Idaho, Sept. 22, 2021 (GLOBE NEWSWIRE) — Today, Idaho First Bank (the ‘Bank’) (OTCPINK: IDFB) announced the addition of Melissa Leon to the Bank’s Boise corporate office as VP, Human Resources (HR) Director. In her new role, Melissa is responsible for managing the “people needs” of a growing company, including, but not limited to onboarding, talent acquisition, performance review standards, and streamlining HR processes and procedures. “I couldn’t be more excited to bring my experience and skills to the Idaho First Bank team,” said Melissa Leon, VP, Human Resources Director of Idaho First Bank. “Everyone has been so welcoming and friendly. I’m eager to expand my knowledge of the banking industry while improving standards to ensure greater bandwidth for growth in the markets we serve.” Prior to joining the Bank, Melissa worked...

BRENTWOOD, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) announced today that it successfully upsized and priced its offering of an additional $225,000,000 aggregate principal amount of CoreCivic’s 8.25% senior unsecured notes due 2026 (the “Additional Notes”). The aggregate principal amount of the Additional Notes to be issued in the offering was increased to $225 million from the previously announced $100 million. The Additional Notes were priced at 102.25% of their aggregate principal amount, plus accrued interest from April 14, 2021, the issue date for CoreCivic’s previously issued $450 million aggregate principal amount of 8.25% senior unsecured notes due 2026 (the “Existing Notes”). The Additional Notes will have an effective yield to maturity of 7.65% and will constitute a single class...

LODI, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp (OTCQX: FMCB) today communicated that Kenneth W. Smith, Executive Vice President and Chief Credit Officer, has announced his intention to retire effective December 31, 2021, after 46 years in banking, including 22 years with Farmers & Merchants Bank of Central California. The Chief Credit Officer position will be filled by Jay J. Colombini, one of the Bank’s two current Executive Vice President and Wholesale Banking Division Managers. Jay Colombini will assume the Chief Credit Officer’s role November 1, 2021 and work closely with Ken Smith until year-end to ensure a seamless transition. Jay Colombini brings to this new position 36 years of industry credit administration experience, including 28 years at Farmers & Merchants Bank of Central...

Press Release Immunocore announces publication of phase 3 data comparing tebentafusp with investigator’s choice in The New England Journal of Medicine Tebentafusp demonstrated prolonged overall survival (OS) compared to investigator’s choice therapy in previously untreated, metastatic uveal melanoma patients Tebentafusp is first T cell receptor (TCR) therapeutic to demonstrate a survival benefit (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 22 September 2021) Immunocore Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infection and autoimmune disease, today announces that data from a phase 3 randomized trial comparing tebentafusp (IMCgp100)...

NEW YORK and BOULDER, Colo., Sept. 22, 2021 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in AI-data driven proteomics technology, today is announcing upcoming conference participation in addition to its analyst meeting. Event Details: SomaLogic Analyst MeetingFormat: Virtual event for the sell-side communityDate: Tuesday, Sept. 28, 2021Time: 11:00am ET Bank of America Life Sciences & Medical Technology Innovation ForumFormat: Panel DiscussionPanel Title: Proteomics: The Next GenerationDate: Wednesday, Sept. 29, 2021Time: 11:00am ETNote: The panel will stream live on the Bank of America conference website The Analyst Meeting held on September 28, 2021 will be in lieu of the combined Analyst and Investor Meeting previously announced. While this meeting will be accessible to sell-side analyst community only, an investor event...

TORONTO, Sept. 22, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce webcast link for the Annual General Meeting of the shareholders of Blueberries Medical Corp. (the “AGM” or “Meeting”). The AGM will be held on Wednesday, September 29th, 2021 at 1:00 pm Eastern Time. Due to the fact that in Ontario a proof of vaccination is required to any shareholders that may want to come to the AGM in person, the company decided to proactively deal with the unprecedented public health impact of COVID-19 and Provincial and Federal guidance regarding public gatherings, shareholders and proxyholders are invited only to attend the online Meeting following...

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — Alpha Cognition Inc. (“Alpha” or the “Company”) (TSXV:ACOG), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce it has commenced an overnight marketed public offering (the “Offering”) of units (the “Units”) of the Company. The Offering will be conducted on a best efforts agency basis pursuant to the terms and conditions of an agency agreement to be entered into between the Company and Raymond James Ltd. as sole bookrunner and lead agent on behalf of a syndicate of agents (collectively, the “Agents”). The defining pricing, terms and size of the Offering will...